WVE (Wave Life Sciences Corp) Tezkor likvidlik koeffitsiyenti

Wave Life Sciences Ltd. (WVE) kompaniyasining rasmiy ramzlari

Wave Life Sciences (WVE) barqarorligi uning joriy likvidlik rezervi va tibbiy test natijalariga bog'liq bo'lib, ko'rsatkich 8.62 darajasida turibdi. Kompaniya neyrodegenerativ patologiyalar uchun terapiyalarni ishlab chiqib, sog'liqni saqlash gigantlaridan litsenziya royalti to'lovlari orqali daromad keltiradi. Ushbu narxlar grafigi emitentning bozor dinamikasini vizuallashtiradi. Biznes qiymatining o'sishi mushak distrofiyasi va Huntington kasalligini davolashdagi yutuqlar, shuningdek, GSK tomonidan ko'rsatilgan qo'llab-quvvatlash bilan ta'minlanmoqda.

WVE: Wave Life Sciences Corp Oraliq qoplash koeffitsiyenti 04.07.2022 - 29.10.2026

wavelifesciences.com (WVE) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Aksiya kotirovkalari Wave Life Sciences Corp|WVE - Maqsadli narxlar grafigi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Wave Life Sciences Corp|WVE - Korxonaning umumiy qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya uchun buxgalteriya qiymati Wave Life Sciences|WVE - Kompaniyaning buxgalteriya qiymati|Bozor qiymatining balans qiymatiga nisbati wavelifesciences.com|WVE - Kompaniyaning jami aktivlari
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning kapitalga nisbati Wave Life Sciences|WVE - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Wave Life Sciences Ltd.|WVE - Kompaniyaning jamlangan qarzdorligi|Balans kapitallashuviga qarzlar Wave Life Sciences Corp|WVE - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli majburiyatlari Wave Life Sciences|Tezkor likvidlik wavelifesciences.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
WVE - Sof moliyaviy natija
Kompaniyaning umumiy tahlili:Wave Life Sciences Corp - WVE
wavelifesciences.com yetakchi tovari

Tezkor koeffitsient kompaniyaning illikvid zaxiralarni butunlay chiqarib tashlagan holda, faqat naqd pul va debitorlik qarzlari hisobiga o'zining zudlik bilan bajarilishi lozim bo'lgan majburiyatlarini qoplash qobiliyatini o'lchaydi. Tezkor likvidlik tendentsiyalarini tahlil qilish orqali investor Wave Life Sciences (WVE) kompaniyasining haqiqiy to'lov qobiliyatini baholaydi, bu esa kutilmagan naqd pul tanqisligi xavfisiz aniq RNA sintezi bo'yicha qimmat turadigan tadqiqot va ishlanmalarni davom ettirish uchun juda muhimdir.

Raqobatdosh kompaniyalar tahlili

TEM (Tempus) - Tezkor likvidlik ko‘rsatkichi|QGEN (Qiagen Corp) - Tezkor likvidlik|IONS (Ionis Pharmaceuticals) - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik repligen.com RGEN|Tezkor likvidlik ko‘rsatkichi RNA (Avidity Biosciences, Inc.)|CRSP (CRISPR Therapeutics Inc) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Sema4 WGS|Ultragenyx Corp - Tezkor likvidlik|Beam Therapeutics Inc. - Tezkor likvidlik koeffitsiyenti|Oraliq qoplama koeffitsiyenti sarepta.com SRPT|TWST: Tezkor likvidlik koeffitsiyenti|Kritik likvidlik koeffitsiyenti TXG (10x Genomics Inc)|NTLA (Intellia) - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Stoke Corp STOK|Tezkor likvidlik ko‘rsatkichi BLFS (BioLife Solutions, Inc.)|MAZE (mazetx.com) - Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Sionna Therapeutics SION|Oraliq qoplama koeffitsiyenti Prime Medicine Inc (PRME)|Taysha - Tezkor likvidlik koeffitsiyenti|uniQure Pharma (QURE) - Tezkor likvidlik ko‘rsatkichi|MGTX: Tezkor likvidlik koeffitsiyenti|RGNX - Oraliq qoplama koeffitsiyenti|SLDB (Solid Biosciences) - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Ocugen Inc OCGN|Tezkor likvidlik Pacific Biosciences of California (PACB)|Benitec Corp - Shoshilinch likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti DSGN (Design Therapeutics)|RCKT - Tezkor likvidlik ko‘rsatkichi|4D Molecular Therapeutics, Inc. - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Lexeo Therapeutics|korrobio.com (KRRO) - Tezkor likvidlik|EDIT - Oraliq qoplama koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi SLN|Tezkor likvidlik ko‘rsatkichi ProQR Therapeutics NV (PRQR)|Tezkor likvidlik ko‘rsatkichi CDXS (Codexis, Inc.)|Tezkor likvidlik SGMO (Sangamo Therapeutics Inc.)|Tezkor likvidlik koeffitsiyenti NAUT (Nautilus Bio)|Metagenomi Therapeutics (MGX) - Shoshilinch likvidlik|Precision BioSciences, Inc. - Tezkor likvidlik koeffitsiyenti|GBIO (Generation Bio Co.) - Shoshilinch likvidlik koeffitsiyenti|Boundless Bio (BOLD) - Tezkor likvidlik|Shoshilinch likvidlik koeffitsiyenti XCUR|IMNN (Imunon Inc) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti RXi Pharmaceuticals|Tezkor likvidlik ko‘rsatkichi MBIO (Mustang Bio, Inc.)|Tezkor likvidlik ko‘rsatkichi transcodetherapeutics.com RNAZ|Tezkor likvidlik koeffitsiyenti BNGO (Bionano Genomics)|Tezkor likvidlik koeffitsiyenti Applied DNA Sciences Inc APDN|BLUE: Tezkor likvidlik ko‘rsatkichi|IPA: Tezkor likvidlik|OMGA: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik singulargenomics.com (OMIC)|Tezkor likvidlik ko‘rsatkichi RGLS|SYRS: Oraliq qoplash koeffitsiyenti|Tezkor likvidlik Codex DNA (TBIO)|Tezkor likvidlik TCON (TRACON Pharmaceuticals, Inc)|Tezkor likvidlik koeffitsiyenti UBX (Unity Biotechnology)